Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3178)
All Articles published online
|
Nov 7, 2006 (publication date) through May 2, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | You J, Zhuang L, Cheng HY, Yan SM, Yu L, Huang JH, Tang BZ, Huang ML, Ma YL, Chongsuvivatwong V, Sriplung H, Geater A, Qiao YW, Wu RX. Efficacy of thymosin alpha-1 and interferon alpha in treatment of chronic viral hepatitis B: A randomized controlled study. World J Gastroenterol 2006; 12(41): 6715-6721 [PMID: 17075991 DOI: 10.3748/wjg.v12.i41.6715] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i41/6715.htm |
| Number | Citing Articles |
| 1 |
|
| 2 |
Miguel-Angel Elizondo-Riojas, Steven M. Chamow, Cynthia W. Tuthill, David G. Gorenstein, David E. Volk. NMR structure of human thymosin alpha-1. Biochemical and Biophysical Research Communications 2011; 416(3-4): 356 doi: 10.1016/j.bbrc.2011.11.041
|
| 3 |
ANDREA V. PAGE, W. CONRAD LILES. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 2010; : 611 doi: 10.1016/B978-0-443-06839-3.00042-4
|
| 4 |
A. Ciancio, M. Rizzetto. Thymalfasin in the treatment of hepatitis B and C. Annals of the New York Academy of Sciences 2010; 1194(1): 141 doi: 10.1111/j.1749-6632.2010.05487.x
|
| 5 |
Bo Hyun Kim, Youn-Jae Lee, Won Kim, Jung-Hwan Yoon, Eun Uk Jung, Sung Jae Park, Yoon Jun Kim, Hyo-Suk Lee. Efficacy of thymosin α-1 plus peginterferon α-2a combination therapy compared with peginterferon α-2a monotherapy in HBeAg-positive chronic hepatitis B: A prospective, multicenter, randomized, open-label study. Scandinavian Journal of Gastroenterology 2012; 47(8-9): 1048 doi: 10.3109/00365521.2012.694902
|
| 6 |
Martina Severa, Jing Zhang, Elena Giacomini, Fabiana Rizzo, Marilena Paola Etna, Melania Cruciani, Enrico Garaci, Michael Chopp, Eliana Marina Coccia. Thymosins in multiple sclerosis and its experimental models: moving from basic to clinical application. Multiple Sclerosis and Related Disorders 2019; 27: 52 doi: 10.1016/j.msard.2018.09.035
|
| 7 |
Yong-Rong Liang, Zhe Guo, Jing-Hang Jiang, Bang-De Xiang, Le-Qun Li. Thymosin α1 therapy subsequent to radical hepatectomy in patients with hepatitis B virus-associated hepatocellular carcinoma: A retrospective controlled study. Oncology Letters 2016; 12(5): 3513 doi: 10.3892/ol.2016.5121
|
| 8 |
Haruka Kobayashi, Yue Yu, David E. Volk. Hormonal Signaling in Biology and Medicine. 2020; : 311 doi: 10.1016/B978-0-12-813814-4.00013-4
|
| 9 |
C. Trépo, F. Zoulim. Traitement de l’hépatite B : progrès attendus. Gastroentérologie Clinique et Biologique 2009; 33(8-9): 811 doi: 10.1016/j.gcb.2009.04.005
|
| 10 |
Norah Htet Htet, Cho Naing, Sompong Vongpunsawad, Thin Thin Win, Yong Poovorawan. Thymosin-ɑ1 for people with chronic hepatitis B. Cochrane Database of Systematic Reviews 2022; 2022(3) doi: 10.1002/14651858.CD014610
|
| 11 |
Walter Mandaliti, Ridvan Nepravishta, Francesca Pica, Paola Sinibaldi Vallebona, Enrico Garaci, Maurizio Paci. Potential mechanism of thymosin-α1-membrane interactions leading to pleiotropy: experimental evidence and hypotheses. Expert Opinion on Biological Therapy 2018; 18(sup1): 33 doi: 10.1080/14712598.2018.1456527
|
| 12 |
Fangjie Liu, Bo Qiu, Yu Xi, Yifeng Luo, Qiaoting Luo, Yingjia Wu, Naibin Chen, Rui Zhou, Jinyu Guo, Qingping Wu, Mai Xiong, Hui Liu. Efficacy of Thymosin α1 in Management of Radiation Pneumonitis in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Concurrent Chemoradiotherapy: A Phase 2 Clinical Trial (GASTO-1043). International Journal of Radiation Oncology*Biology*Physics 2022; 114(3): 433 doi: 10.1016/j.ijrobp.2022.07.009
|
| 13 |
Roberto Camerini, Enrico Garaci. Historical review of thymosin α 1 in infectious diseases. Expert Opinion on Biological Therapy 2015; 15(sup1): 117 doi: 10.1517/14712598.2015.1033393
|
| 14 |
Ebtesam A. Al-Suhaimi, Meneerah A. Aljafary, Fadwa M. Alkhulaifi, Hanan A. Aldossary, Thamer Alshammari, Ayman AL-Qaaneh, Razan Aldahhan, Zahra Alkhalifah, Zagit Z. Gaymalov, Adeeb Shehzad, Abdelgadir M. Homeida. Thymus Gland: A Double Edge Sword for Coronaviruses. Vaccines 2021; 9(10): 1119 doi: 10.3390/vaccines9101119
|
| 15 |
Darius Armstrong-James, Thomas S Harrison. Immunotherapy for fungal infections. Current Opinion in Microbiology 2012; 15(4): 434 doi: 10.1016/j.mib.2012.06.001
|
| 16 |
Sheikh Mohammad Fazle Akbar, Mamun Al Mahtab, Sakirul Khan, Osamu Yoshida, Julio Cesar Aguilar, Guillen Nieto Gerardo, Yoichi Hiasa. Innovative Therapies Targeting the Virus and the Host for Treating Chronic Hepatitis B Virus Infection: From Bench to Bedside. Vaccines 2022; 10(5): 746 doi: 10.3390/vaccines10050746
|
| 17 |
|
| 18 |
Sheikh Mohammad Fazle Akbar, Osamu Yoshida, Yoichi Hiasa. Immune therapies against chronic hepatitis B. Journal of Gastroenterology 2022; 57(8): 517 doi: 10.1007/s00535-022-01890-8
|
| 19 |
Robert G. Gish, Stuart C. Gordon, David Nelson, Vinod Rustgi, Israel Rios. A randomized controlled trial of thymalfasin plus transarterial chemoembolization for unresectable hepatocellular carcinoma. Hepatology International 2009; 3(3): 480 doi: 10.1007/s12072-009-9132-3
|
| 20 |
Walter Mandaliti, Ridvan Nepravishta, Paola Sinibaldi Vallebona, Francesca Pica, Enrico Garaci, Maurizio Paci. New studies about the insertion mechanism of Thymosin α1 in negative regions of model membranes as starting point of the bioactivity. Amino Acids 2016; 48(5): 1231 doi: 10.1007/s00726-016-2169-4
|
| 21 |
P. H. Naylor, M. G. Mutchnick. Immunotherapy for hepatitis B in the direct acting antiviral era: Reevaluating the thymosin α1 efficacy trials in the light of a combination therapy approach. Journal of Viral Hepatitis 2018; 25(1): 4 doi: 10.1111/jvh.12807
|
| 22 |
Xutong Shen, Qingqing Li, Fanwen Wang, Jingxiao Bao, Mengting Dai, Heng Zheng, Xingzhen Lao. Generation of a novel long-acting thymosin alpha1-Fc fusion protein and its efficacy for the inhibition of breast cancer in vivo. Biomedicine & Pharmacotherapy 2018; 108: 610 doi: 10.1016/j.biopha.2018.09.064
|
| 23 |
Riccardo Nevola, Domenico Beccia, Valerio Rosato, Rachele Ruocco, Davide Mastrocinque, Angela Villani, Pasquale Perillo, Simona Imbriani, Augusto Delle Femine, Livio Criscuolo, Maria Alfano, Marco La Montagna, Antonio Russo, Raffaele Marfella, Domenico Cozzolino, Ferdinando Carlo Sasso, Luca Rinaldi, Aldo Marrone, Luigi Elio Adinolfi, Ernesto Claar. HBV Infection and Host Interactions: The Role in Viral Persistence and Oncogenesis. International Journal of Molecular Sciences 2023; 24(8): 7651 doi: 10.3390/ijms24087651
|
| 24 |
Fanwen Wang, Caoying Xu, Renhao Peng, Bin Li, Xutong Shen, Heng Zheng, Xingzhen Lao. Effect of a C-end rule modification on antitumor activity of thymosin α1. Biochimie 2018; 154: 99 doi: 10.1016/j.biochi.2018.08.001
|
| 25 |
Margarita Pardo, Javier Bartolomé, Vicente Carreño. Current Therapy of Chronic Hepatitis B. Archives of Medical Research 2007; 38(6): 661 doi: 10.1016/j.arcmed.2006.12.013
|
| 26 |
R. Nepravishta, W. Mandaliti, P.S. Vallebona, F. Pica, E. Garaci, M. Paci. Thymosins. Vitamins and Hormones 2016; 102: 101 doi: 10.1016/bs.vh.2016.04.002
|
| 27 |
Pu Wang, Changhong Wang, Da Chen. Efficacy of thymosin-α-1 in patients with COVID-19: A systematic review and meta-analysis. European Journal of Inflammation 2023; 21 doi: 10.1177/1721727X231197922
|
| 28 |
ENRICO GARACI, CARTESIO FAVALLI, FRANCESCA PICA, PAOLA SINIBALDI VALLEBONA, ANNA TERESA PALAMARA, CLAUDIA MATTEUCCI, PASQUALE PIERIMARCHI, ANNALUCIA SERAFINO, ANTONIO MASTINO, FRANCESCO BISTONI, LUIGINA ROMANI, GUIDO RASI. Thymosin Alpha 1. Annals of the New York Academy of Sciences 2007; 1112(1): 225 doi: 10.1196/annals.1415.044
|
| 29 |
Claudia Matteucci, Antonella Minutolo, Paola Sinibaldi‐Vallebona, Anna Teresa Palamara, Guido Rasi, Antonio Mastino, Enrico Garaci. Transcription profile of human lymphocytes following in vitro treatment with thymosin alpha‐1. Annals of the New York Academy of Sciences 2010; 1194(1): 6 doi: 10.1111/j.1749-6632.2010.05484.x
|
| 30 |
Yong-Feng Yang, Wei Zhao, Yan-Dan Zhong, Yi-Jun Yang, Ling Shen, Ning Zhang, Ping Huang. Comparison of the efficacy of thymosin alpha-1 and interferon alpha in the treatment of chronic hepatitis B: A meta-analysis. Antiviral Research 2008; 77(2): 136 doi: 10.1016/j.antiviral.2007.10.014
|
| 31 |
Walter Mandaliti, Ridvan Nepravishta, Paola Sinibaldi Vallebona, Francesca Pica, Enrico Garaci, Maurizio Paci. Thymosin α1 Interacts with Exposed Phosphatidylserine in Membrane Models and in Cells and Uses Serum Albumin as a Carrier. Biochemistry 2016; 55(10): 1462 doi: 10.1021/acs.biochem.5b01345
|
| 32 |
Claudia Matteucci, Antonella Minutolo, Michela Pollicita, Emanuela Balestrieri, Sandro Grelli, Gabriella D’Ettorre, Vincenzo Vullo, Ilaria Bucci, Alessandra Luchini, Stefano Aquaro, Paola Sinibaldi-Vallebona, Beatrice Macchi, Carlo Federico Perno, Antonio Mastino, Enrico Garaci. Thymosin α 1 potentiates the release by CD8+cells of soluble factors able to inhibit HIV-1 and human T lymphotropic virus 1 infectionin vitro. Expert Opinion on Biological Therapy 2015; 15(sup1): 83 doi: 10.1517/14712598.2015.1021677
|
| 33 |
Walter Mandaliti, Ridvan Nepravishta, Francesca Pica, Paola Sinibaldi Vallebona, Enrico Garaci, Maurizio Paci. Thymosin α1 Interacts with Hyaluronic Acid Electrostatically by Its Terminal Sequence LKEKK. Molecules 2017; 22(11): 1843 doi: 10.3390/molecules22111843
|
| 34 |
Fanwen Wang, Bin Li, Pengcheng Fu, Qingqing Li, Heng Zheng, Xingzhen Lao. Immunomodulatory and enhanced antitumor activity of a modified thymosin α1 in melanoma and lung cancer. International Journal of Pharmaceutics 2018; 547(1-2): 611 doi: 10.1016/j.ijpharm.2018.06.041
|
| 35 |
Sheikh Mohammad Fazle Akbar, Mamun Al Mahtab, Osamu Yoshida, Julio Aguilar, Guillen Nieto Gerardo, Yoichi Hiasa. Development of Therapy Based on the Exploration of Biological Events Underlying the Pathogenetic Mechanisms of Chronic Hepatitis B Infection. Biomedicines 2023; 11(7): 1944 doi: 10.3390/biomedicines11071944
|
| 36 |
Darren J. Wong, Stephen A. Locarnini, Alexander J.V. Thompson. Clinical Virology. 2016; : 713 doi: 10.1128/9781555819439.ch32
|
| 37 |
David E. Volk, Cynthia W. Tuthill, Miguel‐Angel Elizondo‐Riojas, David G. Gorenstein. NMR structural studies of thymosin α1 and β‐thymosins. Annals of the New York Academy of Sciences 2012; 1270(1): 73 doi: 10.1111/j.1749-6632.2012.06656.x
|